New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Jaydev Thakkar, MBA
Advertisement
Jaydev Thakkar, MBA, MCA, is Chief Operating Officer of Biofourmis
Articles by Jaydev Thakkar, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Artificial Intelligence in Clinical Trials: From Pilots to Practice
2
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5